Clinical Trial Update: Tumor Regression Grade As Predictor of Adjuvant Therapy

View source ↗

Summary

Clinical trial investigating tumor regression grade as a predictor of adjuvant therapy in esophageal squamous cell carcinoma. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Esophageal Squamous Cell Carcinoma (ESCC) | Status: RECRUITING